Trial NCT02429882

View at ClinicalTrials.gov 
Org. Study IDs: 20101228
Secondary IDs: 2014-003701-15

Last trial update was posted on 2015-06-19

MeSH Interventions

Brodalumab

MeSH Conditions

Axial Spondyloarthritis Spondylarthritis Spondylitis

Other Conditions


Stopping Reasons

Per Amgen's decision to discontinue co-development and co-commercialization of brodalumab, study is being cancelled/closed.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID